Nanodisc, Inc. owns commercial license to applications of nano scale and discoidal structures composed of specially engineered proteins and phospholipid bilayers. Nanodiscs offers pharmaceutical researchers and developers a way to work with âcell membrane-associated moleculesâ, such as receptors, ion channels, and enzymes. The firm is developing nano-scale structures consisting of a phospholipid bilayer "disc" surrounded by a Membrane Scaffold Protein (MSP) "belt". Nanodiscs are made through a proprietary process of self-assembly by combining an MSP with phospholipids. The company's technology can be used to manufacture a precise population of these structures that are uniform in size, shape and physical characteristics. The company is researching potential uses for Nanodiscs in medical applications such as drug discovery, target validation, and drug deliv
